The potential application of the spore-forming probiotic Bacillus amyloliquefaciens strain H57 (H57) as a novel probiotic for ruminants was evaluated in reproducing ewes. Performance responses were determined by delivering H57 in a pelleted diet based mainly on palm kernel meal (PKM) and sorghum grain. PKM is an agro-industrial by-product with a reputation for poor palatability and the availability of the starch in sorghum grain can be limited in ruminants. The hypothesis was that H57 improves the feeding value of a relatively low quality concentrate diet. Twenty-four first-parity white Dorper ewes were fed PKM-based pellets manufactured with or without H57 (109 cfu/kg pellet) in late pregnancy. During this phase of late pregnancy, the H57 ewes ate 17% more dry matter (1019 vs 874 g/day, P = 0.03), gained more weight (194 vs 30 g/day, P = 0.008) and retained more nitrogen (6.13 vs 3.34 g/day, P = 0.01), but produced lambs with a similar birthweight (4.1 vs 4.2 kg, P = 0.73). Rumen fluid collected from H57 ewes in late pregnancy had higher pH (7.1 vs 6.8, P = 0.07), acetate : propionate ratio (3.4 vs 2.7, P = 0.04), lower ammonia (69 vs 147 mmol/L, P = 0.001) and total volatile fatty acid concentrations (40 vs 61 mg/L, P = 0.02). The digestibility of dry matter, organic matter and fibre were similar between the two groups. The lambs of the H57 ewes grew faster than those of the Control ewes for the first 21 days of lactation (349 vs 272 g/day, P = 0.03), but not thereafter. H57 can improve feed intake and maternal liveweight gain in late pregnancy of first-parity ewes fed a diet based on PKM.
A spore-forming probiotic, Bacillus amyloliquefaciens strain H57 (H57), was administered to dairy calves in starter pellets to determine effects on liveweight gain, feed conversion efficiency and animal health under summer feeding conditions, without antibiotics. Twenty-four male and female calves were allocated into two groups and from 4 weeks of age individually offered 6 L/day of whole milk and ad libitum starter pellets impregnated with H57 (3.16 × 108 cfu per kg DM) or without (Control) until 12 weeks of age. The calves were housed in a non-air-conditioned animal house, with deep-straw bedding over concrete, under typically challenging subtropical summer conditions. After 12 weeks the calves were released into a grazing paddock as one group and were supplemented ad libitum with control pellets and hay, until 19 weeks of age. From Weeks 4 to 12, liveweight and feed intakes were measured weekly and health status was monitored daily. Rumen fluid and blood were collected at Weeks 4 and 12, and to test for persistence after cessation of feeding H57, each were measured again at Week 19. From Weeks 4 to 12, the H57 calves grew faster (767 vs 551 g/day, P = 0.01), tended to consume more pellets (1013 vs 740 g DM/day, P = 0.07) and were 19% more feed conversion efficiency (2.43 vs 2.90 kg milk + starter DM/kg weight gain, P = 0.01) compared with the Control calves. The mean duration of each diarrhoea event was 2 days less for the H57 calves than the Control (P = 0.01). The H57 calves weaned 9 days earlier (P = 0.02) and were heavier at Week 19 (155 vs 139 kg, P = 0.03) than the Control calves. The only effect of H57 on rumen volatile fatty acid concentrations was an elevation in valerate at Week 12 (4.10 vs 2.47 mmol/L, P = 0.03). Plasma β-hydroxy butyrate was also elevated in the H57 calves at Week 19 (0.24 vs 0.20 mmol/L), indicating the potential of H57 to improve rumen development. H57 can be used to improve the nutritional performance and reduce the risk of diarrhoea in dairy calves as they transition from milk to dry feed.
This study provides a novel look at the rumen prokaryotic community in both sheep and dairy calves when fed H57. These findings improve our understanding for the potential rumen community involvement in H57-enabled weight gain. The study reveals that the probiotic B. amyloliquefaciens H57 is capable of benefiting ruminants without colonizing the rumen, suggesting an indirect mechanism of action.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.